Arrhythmia

Featured Article

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

New ACC/AHA performance and quality measures for atrial fibrillation/flutter include metrics for outpatient care.

Latest Features

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Weighing Benefits and Risks of Anticoagulation in the Elderly

Weighing Benefits and Risks of Anticoagulation in the Elderly

Determining which patients who have atrial fibrillation should receive anticoagulation therapy for stroke prophylaxis can be challenging.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

Premature Ventricle Contractions in Heart Failure: A Closer Examination

Premature Ventricle Contractions in Heart Failure: A Closer Examination

A primer on premature ventricle contractions with commentary from 2 arrhythmic/heart failure experts.

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

ARVD/Cardiomyopathy: Interview with Expert Hugh Calkins, MD

While ARVD/C management has greatly improved, more precautions—particularly in genetic testing and exercise—need to be taken.

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

ACC/AHA Issue Revised Performance and Quality Measures for Atrial Fibrillation

New ACC/AHA performance and quality measures for atrial fibrillation/flutter include metrics for outpatient care.

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Cryoablation vs Radiofrequency Ablation in Atrial Fibrillation

Experts weigh in on cryoablation vs radiofrequency ablation techniques for atrial fibrillation in light of FIRE and ICE trial results.

A Case of Heart Failure Secondary to Mitral Regurgitation

A Case of Heart Failure Secondary to Mitral Regurgitation

Although surgery remains the gold standard in mitral valve repair, percutaneous repair is a new option in the treatment armamentarium, particularly in high-risk settings.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Latest News

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

Long-Detection Programming in Single-Chamber Implantable Cardioverter Defibrillators Reduces Shocks and Pacing

Long-detection programming improved survival, decreased the likelihood of hospitalization, and reduced therapy in patients with single-chamber ICDs.

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

Dementia Risk in Atrial Fibrillation Increases With Delayed Anticoagulation

The delayed start of anticoagulation treatment for atrial fibrillation has been linked to an increase risk for dementia.

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Newly Diagnosed Atrial Fibrillation Benefits From Rivaroxaban, Dabigatran

Direct oral anticoagulation reduced the risk of congestive heart failure admissions and all-cause mortality in both genders.

Wearable Cardioverter Defibrillators Safe, Effective for Pediatric Patients

Wearable Cardioverter Defibrillators Safe, Effective for Pediatric Patients

All arrhythmic episodes were successfully converted, and no deaths were reported.

Implantable Cardiac Devices, Abandoned Leads Pose Little Risk in MRI

Implantable Cardiac Devices, Abandoned Leads Pose Little Risk in MRI

Magnetic resonance imaging appears to be safe in patients with implantable cardiac devices and abandoned leads.

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

Sudden Cardiac Death/Ventricular Arrhythmia Risk in Atrial Fibrillation

The annual risk of sudden cardiac death/ventricular arrhythmias was higher in patients with atrial fibrillation vs patients without atrial fibrillation.

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

Cardiac magnetic resonance was superior to transthoracic echocardiogram in identifying a pathologic substrate in patients with out-of-hospital cardiac arrest.

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-Angiotensin System Inhibition Effect on Post-MI Mortality and New-Onset Atrial Fibrillation

Renin-angiotensin system inhibition was linked with a reduced 3-year risk of all-cause mortality in patients with congestive heart failure and atrial fibrillation.

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

Obesity Paradox Reported for CVD Death Outcomes in Atrial Fibrillation

A systematic review of BMI and major adverse events in AF concluded that further evidence is necessary to clarify the relationship between obesity and AF.

Sign Up for Free e-Newsletters